Lumos Pharma (LUMO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist

4.310
-0.020-0.46%

Close Nov 22 16:00 ET

37.28MMarket Cap-1007P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Lumos Pharma Presents Updated Phase 2 OraGrowtH Data Demonstrating Sustained Growth On Oral LUM-201 To 24 Months In PGHD And Correlation Of Growth To LUM-201's Unique Pulsatile Mechanism Of Action At ESPE 2024
BenzingaNov 21 09:15 ET
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger
TipRanksNov 9 01:01 ET
Hold Rating on Lumos Pharma Amid Financial Challenges and Strategic Merger With Double Point Ventures
TipRanksNov 8 10:55 ET · Ratings
Lumos Pharma | 10-Q: Q3 2024 Earnings Report
SECNov 7 15:13 ET · Announcements
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62nd Annual ESPE Meeting 2024
GlobeNewswireOct 30 16:05 ET
Express News | Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual Espe Meeting 2024
ReutersOct 30 16:05 ET

Comments

Jaguar8

Nov 21 08:05

NEWS

$Lumos Pharma (LUMO.US)$
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action
Lumos Pharma presented new analyses from Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials at ESPE 2024. The data showed sustained growth on LUM-201 in moderate Pediatric Growth Hormone Deficiency (PGHD) patients over 24 months. Results demonstrated significant increases ...

Jaguar8

Nov 12 17:34

13G

$Lumos Pharma (LUMO.US)$
Lumos Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Private Advisor Group, LLC(9.16%)

Jaguar8

Oct 23 23:18

Put on watch. Merger + FDA alignment news. Low float.

$Lumos Pharma (LUMO.US)$

Trytosaveabit

Oct 23 07:06

A bit more

$Lumos Pharma (LUMO.US)$ Lumos Pharma Company and FDA Are Aligned on the Company's Final Phase 3 Trial Design >LUMO
Dow Jones· 3 mins ago

Trytosaveabit

Oct 23 07:01

News

$Lumos Pharma (LUMO.US)$ Reuters· just
Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR)

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

LUMO Lumos Pharma

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target